Listed

Corcept Therapeutics Inc

CORTNasdaqCIK 1088856HealthcareFiscal year ends Dec 31

Reports and events: 302 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Corcept Therapeutics Inc, Reports and events
FiledFormWhat it isAccession number
2023-08-0216:14 ET10-QQuarterly reportPeriod 2023-06-300001628280-23-026768
2023-08-0216:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-026757
2023-05-2416:06 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001628280-23-019588
2023-05-0316:22 ET10-QQuarterly reportPeriod 2023-03-310001628280-23-015236
2023-05-0316:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-015219
2023-04-1416:16 ETDEF 14AProxy statement0001628280-23-011628
2023-02-2816:31 ET10-KAnnual reportPeriod 2022-12-310001628280-23-005581
2023-02-2816:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-005562
2023-02-1308:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-034374
2022-12-0808:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-300535
2022-11-0316:15 ET10-QQuarterly reportPeriod 2022-09-300001628280-22-028203
2022-11-0316:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-22-028184
2022-09-2216:33 ET8-K1.01 Entry into a material agreement0001193125-22-249225
2022-08-0417:56 ET10-QQuarterly reportPeriod 2022-06-300001628280-22-020731
2022-08-0316:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-22-020614
2022-06-0217:20 ET8-K5.07 Shareholder vote results0001628280-22-016073
2022-05-0516:17 ET10-QQuarterly reportPeriod 2022-03-310001628280-22-012662
2022-05-0516:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-22-012652
2022-04-2516:37 ETDEF 14AProxy statementPeriod 2022-04-250001628280-22-010131
2022-02-1516:22 ET10-KAnnual reportPeriod 2021-12-310001628280-22-002714
2022-02-1516:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-22-002707
2021-12-0808:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-350898
2021-11-1517:07 ET10-K/AAnnual report, amendedPeriod 2020-12-310001193125-21-330090
2021-11-0316:26 ET10-QQuarterly reportPeriod 2021-09-300001628280-21-021485
2021-11-0316:22 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-21-021481
2021-08-1318:32 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-244963
2021-07-2916:31 ET10-QQuarterly reportPeriod 2021-06-300001628280-21-014900
2021-07-2916:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-21-014888
2021-06-1508:32 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001628280-21-012220
2021-06-1013:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-21-011975
2021-06-0216:40 ET8-K5.07 Shareholder vote results0001628280-21-011522
2021-05-0616:21 ET10-QQuarterly reportPeriod 2021-03-310001628280-21-009318
2021-05-0616:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-21-009309
2021-04-2216:07 ETDEF 14AProxy statementPeriod 2021-04-220001628280-21-007363
2021-03-0117:16 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-063823
2021-02-2317:09 ET10-KAnnual reportPeriod 2020-12-310001628280-21-002861
2021-02-2316:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-21-002824
2021-02-0816:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-21-001612
2021-02-0308:31 ET8-K8.01 Other events0001193125-21-026522
2020-11-2317:24 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-20-016730
2020-11-1918:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-20-016580
2020-11-0316:46 ET10-QQuarterly reportPeriod 2020-09-300001628280-20-015376
2020-11-0316:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-20-015361
2020-08-0416:58 ET10-QQuarterly reportPeriod 2020-06-300001628280-20-011656
2020-08-0416:35 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-20-011643
2020-07-1417:05 ET8-K5.02 Departure or appointment of officers or directors0001628280-20-010325
2020-05-2914:23 ET8-K5.07 Shareholder vote results0001628280-20-008606
2020-05-0417:06 ET10-QQuarterly reportPeriod 2020-03-310001628280-20-006270
2020-05-0416:27 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-20-006249
2020-04-2716:15 ETDEF 14AProxy statementPeriod 2020-04-270001628280-20-005588

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:12 ET. Listed shows no prices and gives no investment advice.